title: Rectal cancer.
abstract: These NCCN Clinical Practice Guidelines in Oncology provide recommendations for the management of rectal cancer, beginning with the clinical presentation of the patient to the primary care physician or gastroenterologist through diagnosis, pathologic staging, neoadjuvant treatment, surgical management, adjuvant treatment, surveillance, management of recurrent and metastatic disease, and survivorship. This discussion focuses on localized disease. The NCCN Rectal Cancer Panel believes that a multidisciplinary approach, including representation from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology, is necessary for treating patients with rectal cancer.
authors.affiliation: Robert H. Lurie Comprehensive Cancer Center of Northwestern University, USA.
authors.forename: Al B
authors.initials: AB
authors.lastname: Benson
authors.forename: Tanios
authors.initials: T
authors.lastname: Bekaii-Saab
authors.forename: Emily
authors.initials: E
authors.lastname: Chan
authors.forename: Yi-Jen
authors.initials: YJ
authors.lastname: Chen
authors.forename: Michael A
authors.initials: MA
authors.lastname: Choti
authors.forename: Harry S
authors.initials: HS
authors.lastname: Cooper
authors.forename: Paul F
authors.initials: PF
authors.lastname: Engstrom
authors.forename: Peter C
authors.initials: PC
authors.lastname: Enzinger
authors.forename: Marwan G
authors.initials: MG
authors.lastname: Fakih
authors.forename: Charles S
authors.initials: CS
authors.lastname: Fuchs
authors.forename: Jean L
authors.initials: JL
authors.lastname: Grem
authors.forename: Steven
authors.initials: S
authors.lastname: Hunt
authors.forename: Lucille A
authors.initials: LA
authors.lastname: Leong
authors.forename: Edward
authors.initials: E
authors.lastname: Lin
authors.forename: Michael G
authors.initials: MG
authors.lastname: Martin
authors.forename: Kilian Salerno
authors.initials: KS
authors.lastname: May
authors.forename: Mary F
authors.initials: MF
authors.lastname: Mulcahy
authors.forename: Kate
authors.initials: K
authors.lastname: Murphy
authors.forename: Eric
authors.initials: E
authors.lastname: Rohren
authors.forename: David P
authors.initials: DP
authors.lastname: Ryan
authors.forename: Leonard
authors.initials: L
authors.lastname: Saltz
authors.forename: Sunil
authors.initials: S
authors.lastname: Sharma
authors.forename: David
authors.initials: D
authors.lastname: Shibata
authors.forename: John M
authors.initials: JM
authors.lastname: Skibber
authors.forename: William
authors.initials: W
authors.lastname: Small
authors.forename: Constantinos T
authors.initials: CT
authors.lastname: Sofocleous
authors.forename: Alan P
authors.initials: AP
authors.lastname: Venook
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Willett
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Freedman-Cass
authors.forename: Kristina M
authors.initials: KM
authors.lastname: Gregory
mesh_terms: D003131:Combined Modality Therapy; D020022:Genetic Predisposition to Disease; D017408:Guidelines as Topic; D006801:Humans; D009367:Neoplasm Staging; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D018570:Risk Assessment; D014807:Vitamin D / Q000378:metabolism
chemical_list: D014807:Vitamin D